Publication | Open Access

Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission

ImmunologyGastroenterologyBiochemical RemissionAchieve EndoscopicClinical GastroenterologyUlcerative ColitisMedicinePeak Concentrations